¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

»ï¼º¼­¿ïº´¿ø ´ëÇÑ°áÇÙ¹×È£Èí±âÇÐȸ ILD School 2020 : 2020-03-21

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
»ï¼º¼­¿ïº´¿ø ´ëÇÑ°áÇÙ¹×È£Èí±âÇÐȸ ILD School 2020 : 2020-03-21
±³À°ÀÏÀÚ : 2020-03-21
±³À°Àå¼Ò : »ï¼º¼­¿ïº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç  
±³À°ÁÖÁ¦ : ILD School 2020
ÁÖÃÖ±â°ü : ´ëÇÑ°áÇÙ¹×È£Èí±âÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : °£Áú¼ºÆóÁúȯ(ILD)¿¬±¸È¸
´ã´çÀÚ : ±è½ÃÀ±
¿¬¶ôó : 02-575-3825  
À̸ÞÀÏ : katrd@hanmail.net      
±³À°Á¾·ù : ³»°ú, °áÇÙ°ú      
Âü¼®¿¹»óÀοø : 100¸í
Èñ¸ÁÆòÁ¡ : 3Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 3 ½Ã°£ 0ºÐ  
¼¼ºÎ¼ö°­·á : 10,000¿ø      
ºñ°í »çÀüµî·Ï : 10,000¿ø ÇöÀåµî·Ï : 20,000¿ø      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 03-21 ÁöÇÏ1Ãþ ´ë°­´ç 14:10~14:40 Idiopathic Pulmonary Fibrosis: Current Management and Future Perspectives  ÃÖ¼±¹Ì(¼­¿ïÀÇ´ë ³»°ú) 
±³À°½Ã°£ 03-21 ÁöÇÏ1Ãþ ´ë°­´ç 14:40~15:10 An Evolving ILD : Pleuroparenchymal Fibroelastosis  ÀÌÀçÇÏ(ÀÎÁ¦ÀÇ´ë ³»°ú) 
±³À°½Ã°£ 03-21 ÁöÇÏ1Ãþ ´ë°­´ç 15:10~15:40 Diagnostic Approach to Diffuse Cystic Lung Disease: Radiologists¡¯ Perspectives  Ã¤ÀºÁø(¿ï»êÀÇ´ë ³»°ú) 
±³À°½Ã°£ 03-21 ÁöÇÏ1Ãþ ´ë°­´ç 16:10~16:40 Progressive Fibrosing-ILD: Concept and Pharmacologic Management  ¼ÛÁø¿ì(¿ï»êÀÇ´ë ³»°ú) 
±³À°½Ã°£ 03-21 ÁöÇÏ1Ãþ ´ë°­´ç 16:40~17:10 Systemic Sclerosis Associated ILD: where do we stand  ÀÌÁ¾¹Î(°¡Å縯ÀÇ´ë ³»°ú) 
±³À°½Ã°£ 03-21 ÁöÇÏ1Ãþ ´ë°­´ç 17:10~17:40 Chronic Hypersensitivity Pneumonitis: the New Diagnostic Criteria and Treatment  À¯È«¼®(¼º±Õ°üÀÇ´ë ³»°ú) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" »ï¼º¼­¿ïº´¿ø ´ëÇÑ°áÇÙ¹×È£Èí±âÇÐȸ ILD School 2020 : 2020-03-21""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û °æºÏ´ëÇб³º´¿ø ¿µ³² ³»°ú°è ½ÅÀåÀÌ½Ä ¿¬±¸È¸ Á¦25Â÷ ÇмúÁý´ãȸ : 2020-03-21
´ÙÀ½±Û 2020 ºÎ»ê¿ï»ê°æ³²Ä¡¸ÅÇÐȸ Ãá°èÇмú´ëȸ : 2020-03-21
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20484 ¼­¿ï ´ëÇѼҾÆû¼Ò³â½Å°æ¿Ü°úÇÐȸ Á¦36Â÷ Á¤±âÇмú´ëȸ : 2024-05-10 0 52 2024-04-29
20483 ±¤ÁÖ 2024³â ´ëÇѼҾƺñ´¢ÀÇÇÐȸ Á¦37Â÷ Çмú´ëȸDAY1 : 2024-05-10 0 48 2024-04-29
20482 ¼­¿ï 2024³âµµ Á¦71Â÷ ´ëÇÑÁ÷¾÷ȯ°æÀÇÇÐȸ º½Çмú´ëȸ : 2024-05-10 0 68 2024-04-29
20481 °æ±â ´ëÇѺÎÀÎÁ¾¾ç¿¬±¸È¸ KGOG 2024 Spring Semi-Annual Meeting (1ÀÏÂ÷) : 2024-05-10 0 86 2024-04-29
20480 °­¿ø 2024³â ´ëÇѺ´¸®ÇÐȸ º½Çмú´ëȸ(1ÀÏÂ÷) : 2024-05-09 0 52 2024-04-29
20479 ¼­¿ï (¿Â¶óÀÎ) ÀÇ·á±â°ü Á¾»çÀÚ ´ë»ó ¿¬¸íÀÇ·á°áÁ¤Á¦µµ ±âº»±³À° : 2024-05-09 0 53 2024-04-29
20478 ¼­¿ï (¿Â¶óÀÎ) ÀÇ·á±â°ü Á¾»çÀÚ(ÀÇ·áÀÎ) ´ë»ó ¿¬¸íÀÇ·á°áÁ¤Á¦µµ ½ÉÈ­±³À° : 2024-05-09 0 49 2024-04-29
20477 ºÎ»ê ´ëÇÑ°£ÇÐȸ ºÎ»ê¿ï»ê°æ³²Áöȸ Áý´ãȸ(°£¼¼Æ÷¾ÏÀÇ downstaging: Çö½Ç°ú ¹Ì·¡) : 2024-05-09 0 61 2024-04-29
20476 ÀÎõ Çѱ¹¿©ÀÚÀÇ»çȸ ÀÎõÁöȸ 5¿ù Çмú½ÉÆ÷Áö¾ö : 2024-05-09 0 44 2024-04-29
20475 Á¦ÁÖ ´ëÇÑ°áÇÙ ¹× È£Èí±âÇÐȸ Á¦ÁÖÁöȸ 5¿ù ¿¬¼ö°­Á : 2024-05-08 0 57 2024-04-29
20474 Á¦ÁÖ (3ÀÏÂ÷) 2024³â Á¦24Â÷ Çѱ¹Á¶Á÷°øÇС¤Àç»ýÀÇÇÐȸ Á¤±âÇмú´ëȸ : 2024-05-04 0 42 2024-04-29
20473 Á¦ÁÖ (2ÀÏÂ÷) 2024³â Á¦24Â÷ Çѱ¹Á¶Á÷°øÇС¤Àç»ýÀÇÇÐȸ Á¤±âÇмú´ëȸ : 2024-05-03 0 37 2024-04-29
20472 ÀüºÏ ´ëÇÑÇǺÎÁø±Õ ¹× °¨¿°ÇÐȸ ¼øȸ¿¬¼ö±³À° : 2024-05-03 0 54 2024-04-29
20471 Á¦ÁÖ (1ÀÏÂ÷) 2024³â Á¦24Â÷ Çѱ¹Á¶Á÷°øÇС¤Àç»ýÀÇÇÐȸ Á¤±âÇмú´ëȸ : 2024-05-02 0 42 2024-04-29
20470 ´ë±¸ Á¦ 263Â÷ ´ëÇÑ ÇǺΰúÇÐȸ ´ë±¸°æºÏÁöºÎ Áý´ãȸ(¿øÇü Å»¸ð) : 2024-05-02 0 39 2024-04-29
11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷